Table 2: Clinicopathologic features of patients according to MSI status.

Feature

 

MSI

MSS

p value

Stage

I

5 (26.3%)

35 (43.8%)

0.014

II

6 (31.6%)

35 (43.8%)

 

III

8 (42.1%)

8 (10%)

 

IV

0 (0%)

2 (2.5%)

 

Stage

I, II

11 (57.9%)

70 (87.5%)

0.006

III,IV

8 (42.1%)

10 (12.5%)

 

Myometrial invasion

< 1/2

9 (47.4%)

42 (52.5%)

0.883

≥ 1/2

10 (52.6%)

38 (47.5%)

 

Low uterine Segment +

No

9 (47.4%)

37 (46.3%)

1.000

Yes

10 (52.6%)

43 (53.8%)

 

LVÄ°

No

9 (50%)

57 (71.3%)

0.145

Yes

9 (50%)

23 (28.8%)

 

Grade

1

2 (10.5%)

24 (30.4%)

0.080

2

13 (68.4%)

32 (40.5%)

 

3

4 (21.1%)

23 (29.1%)

 

Lymph node +

No

12 (63.2%)

60 (89.6%)

0.012

Yes

7 (36.8%)

7 (10.4%)

 

Age

< 60

12 (63.2%)

26 (32.5%)

0.027

≥ 60

7 (36.8%)

54 (67.5%)

 

Local recurrence

No

17 (89.4%)

73 (91.2%)

0.586

Yes

2 (10.5%)

7 (8.7%)

 

Distant recurrence

No

18 (94.7%)

78 (97.5%)

0.141

Yes

1 (5.2%)

2 (2.5%)